Print

HVTN 094

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected Vaccinia-Naive Adults

Trial Details:

I Completed
GeoVax, National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) May 24, 2012
GEO-D03 ,MVA/HIV62 DNA Gag, PR, RT, Env, Tat, Rev, Vpu; Pox Gag, Evn, Pol B
GEO-D03 DNA
MVA/HIV62 Viral Vector - Pox
GM-CSF
USA 48
NCT01571960
http://clinicaltrials.gov/ct2/show/NCT01571960?term=hiv+vaccine&lup_s=03%2F10%2F2012&lup_d=30